American healthcare spending has surpassed $5 trillion annually and continues to rise faster than inflation and wages: hospitals warn of financial distress, primary care says it is underfunded, rural hospitals …
Category:
Health
-
-
The flux around CMS Star Ratings continues. Lawsuits from health insurers over Medicare Advantage Star Ratings have increased in recent years, though with varying results. Some plans like SCAN and …
-
A Viridian Therapeutics drug for thyroid eye disease now has FDA approval, making it just the second therapy for this inflammatory disorder and one offering key competitive advantages over the …
-
Health
A Bridge to Nowhere? Medicare’s GLP-1 Coverage Expansion Requires A More Holistic Approach To Weight Management
Medicare is about to launch an experiment of historic scale. Beginning in July, seniors with a diagnosis of obesity will be able to access GLP-1 medications with a $50 co-pay …
-
On Thursday, I was among roughly 15 journalists, influencers and industry analysts invited to the headquarters of UnitedHealthcare and Optum in Eden Prairie, Minnesota. When the invitation came a month …
-
Upside, a housing stability platform partnering with health insurers, announced Thursday that it raised $20 million in Series A funding. The company’s AI-powered platform helps payers and employers identify members …
-
Healthcare has spent the better part of a decade building data lakes. The original problem was straightforward and worth solving: clinical data lived in silos, providers could not see the …
-
Healthcare has gotten good at finishing things. Discharge instructions are handed over. Follow-ups are scheduled. Portal accounts are created. Bills go out on time. Every one of those is a …
-
Health
Documentation Tools Aren’t Just for Doctors: Inside Reid Health’s Deployment of Abridge’s Nurse Tech
The clinical burnout crisis in the U.S. has been making headlines for years, and it continues to remain an unsolved problem. Stress and burnout levels have fallen a bit since …
-
Regulatory pressure is mounting on Amgen’s inflammatory disorder drug, Tavneos, with the European Medicines Agency recommending revocation of the product’s approval in its territory. The move follows an FDA proposal …